Logo

UCB Deploys Genedata's Software to Support Drug Programs

May 30, 2007
NEW YORK (GenomeWeb News) — Belgian biopharmaceutical company UCB is using two of Genedata's software platforms to support its drug-development programs, Genedata said today.
 
Genedata said UCB has deployed the integrated Phylosopher and Expressionist software platforms. The drug maker will use the platforms to study CNS disorders, allergy and respiratory diseases, immune and inflammatory disorders, and oncology.
 
Expressionist, which is used in biomarker research, is a modular enterprise system that includes public and private data and sample information.
 
Phylosopher, meantime, integrates proprietary information with public data and links information such as genome sequences and transcriptomic, proteomic, and metabolomic data with functional information and annotations. It also links phenotypes relevant to disease.
 
Financial terms of the agreement were not released.

Filed under

Informatics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.